A systematic approach to obtain validated partial least square models for predicting lipoprotein subclasses from serum NMR spectra.

A systematic approach is described for building validated PLS models that predict cholesterol and triglyceride concentrations in lipoprotein subclasses in fasting serum from a normolipidemic, healthy population. The PLS models were built on diffusion-edited (1)H NMR spectra and calibrated on HPLC-derived lipoprotein subclasses. The PLS models were validated using an independent test set. In addition to total VLDL, LDL, and HDL lipoproteins, statistically significant PLS models were obtained for 13 subclasses, including 5 VLDLs (particle size 64-31.3 nm), 4 LDLs (particle size 28.6-20.7 nm) and 4 HDLs (particle size 13.5-9.8 nm). The best models were obtained for triglycerides in VLDL (0.82 < Q(2) <0.92) and HDL (0.69 < Q(2) <0.79) subclasses and for cholesterol in HDL subclasses (0.68 < Q(2) <0.96). Larger variations in the model performance were observed for triglycerides in LDL subclasses and cholesterol in VLDL and LDL subclasses. The potential of the NMR-PLS model was assessed by comparing the LPD of 52 subjects before and after a 4-week treatment with dietary supplements that were hypothesized to change blood lipids. The supplements induced significant (p < 0.001) changes on multiple subclasses, all of which clearly exceeded the prediction errors.

[1]  Francesco Savorani,et al.  NMR and interval PLS as reliable methods for determination of cholesterol in rodent lipoprotein fractions , 2010, Metabolomics.

[2]  Ken Williams,et al.  Nuclear Magnetic Resonance Lipoprotein Abnormalities in Prediabetic Subjects in the Insulin Resistance Atherosclerosis Study , 2005, Circulation.

[3]  S. Yamashita,et al.  Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[4]  Søren Balling Engelsen,et al.  Quantification of lipoprotein subclasses by proton nuclear magnetic resonance-based partial least-squares regression models. , 2005, Clinical chemistry.

[5]  L. Groop,et al.  Hyperinsulinemia and insulin resistance are associated with multiple abnormalities of lipoprotein subclasses in glucose-tolerant relatives of NIDDM patients. Botnia Study Group. , 1996, Journal of lipid research.

[6]  D W Bennett,et al.  Quantification of plasma lipoproteins by proton nuclear magnetic resonance spectroscopy. , 1991, Clinical chemistry.

[7]  J. Otvos,et al.  Measurement of lipoprotein subclass profiles by nuclear magnetic resonance spectroscopy. , 2002, Clinical laboratory.

[8]  J. Saltevo,et al.  High serum adiponectin is associated with favorable lipoprotein subclass profile in 6.4-year follow-up. , 2011, European journal of endocrinology.

[9]  L. A. Stone,et al.  Computer Aided Design of Experiments , 1969 .

[10]  R. Krauss,et al.  Development of a proton nuclear magnetic resonance spectroscopic method for determining plasma lipoprotein concentrations and subspecies distributions from a single, rapid measurement. , 1992, Clinical chemistry.

[11]  Reino Laatikainen,et al.  High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism. , 2009, The Analyst.

[12]  Kimmo Kaski,et al.  The inherent accuracy of 1H NMR spectroscopy to quantify plasma lipoproteins is subclass dependent. , 2007, Atherosclerosis.

[13]  T. Bathen,et al.  Quantification of plasma lipids and apolipoproteins by use of proton NMR spectroscopy, multivariate and neural network analysis , 2000, NMR in biomedicine.

[14]  M. Ala-Korpela Potential role of body fluid 1H NMR metabonomics as a prognostic and diagnostic tool , 2007, Expert review of molecular diagnostics.

[15]  Donald A. Smith,et al.  Advanced lipoprotein testing: recommendations based on current evidence. , 2009, Endocrinology and metabolism clinics of North America.

[16]  P. Barter,et al.  Precursor-product relationship between pools of very low density lipoprotein triglyceride. , 1972, The Journal of clinical investigation.

[17]  D. Bilheimer,et al.  On the metabolic conversion of human plasma very low density lipoprotein to low density lipoprotein. , 1973, Biochimica et biophysica acta.

[18]  A. Astrup,et al.  High throughput prediction of chylomicron triglycerides in human plasma by nuclear magnetic resonance and chemometrics , 2010, Nutrition & metabolism.

[19]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[20]  Olav M. Kvalheim,et al.  Interpretation of partial least squares regression models by means of target projection and selectivity ratio plots , 2010 .

[21]  Aki Vehtari,et al.  A novel Bayesian approach to quantify clinical variables and to determine their spectroscopic counterparts in 1H NMR metabonomic data , 2007, BMC Bioinformatics.

[22]  Rasmus Bro,et al.  Analysis of lipoproteins using 2D diffusion-edited NMR spectroscopy and multi-way chemometrics , 2005 .

[23]  G. Morris,et al.  Particle size measurement of lipoprotein fractions using diffusion-ordered NMR spectroscopy , 2012, Analytical and Bioanalytical Chemistry.

[24]  C. Packard,et al.  Distinct patterns of heparin affinity chromatography VLDL1 and VLDL2 subfractions in the different dyslipidaemias. , 2008, Atherosclerosis.